4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetr ahydropyridine derivatives as serotonin reuptake inhibitors

Details for Australian Patent Application No. 2004226319 (hide)

International Classifications

Event Publications

20 October 2005 PCT application entered the National Phase

PCT publication WO2004/087662 Priority application(s): WO2004/087662

1 December 2005 Amendment Made

The nature of the amendment is: Delete priority details 60/460,266 4 Apr 2003 US 2004226837 H. Lundbeck A/S The nature of the amendment is: Delete priority details 60/460,265 US 04 APR 2003

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.